Human Ubc9 Is Involved in Intracellular HIV-1 Env Stability after Trafficking out of the Trans-Golgi Network in a Gag Dependent Manner

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Bohl, Christopher R ^a,b   Abrahamyan, Levon G ^a   Wood, Charles ^a  

^a UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 160; PROTEIN UBC9; UVOMORULIN; VIRUS ENVELOPE PROTEIN;

ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM ASSOCIATED DEGRADATION; HUMAN IMMUNODEFICIENCY VIRUS 1; LIPID RAFT; LYSOSOME; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN STABILITY; PROTEIN TRANSPORT; TRANS GOLGI NETWORK; UNFOLDED PROTEIN RESPONSE; VIRION; VIRUS ASSEMBLY;

CADHERINS; ENDOPLASMIC RETICULUM STRESS; ENDOPLASMIC RETICULUM-ASSOCIATED DEGRADATION; FURIN; GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; GENE KNOCKDOWN TECHNIQUES; HEK293 CELLS; HIV ENVELOPE PROTEIN GP120; HIV ENVELOPE PROTEIN GP160; HIV-1; HUMANS; INTRACELLULAR SPACE; LEUPEPTINS; LYSOSOMES; MEMBRANE MICRODOMAINS; MODELS, BIOLOGICAL; PROTEASOME INHIBITORS; PROTEIN STABILITY; PROTEIN TRANSPORT; PROTEOLYSIS; TRANS-GOLGI NETWORK; UBIQUITIN-CONJUGATING ENZYMES;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84879985060     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0069359     Document Type: Article

References (117)

1. Freed EO, (1998) HIV-1 gag proteins: diverse functions in the virus life cycle. Virology 251: 1-15. doi:10.1006/viro.1998.9398. PubMed: 9813197.
2. Wills JW, Craven RC, (1991) Form, function, and use of retroviral gag proteins. AIDS 5: 639-654. doi:10.1097/00002030-199106000-00002. PubMed: 1883539.
3. Swanstrom R, Wills JW, (1997) Synthesis, Assembly, and Processing of Viral Proteins.
4. Blot G, Janvier K, Le Panse S, Benarous R, Berlioz-Torrent C, (2003) Targeting of the human immunodeficiency virus type 1 envelope to the trans-Golgi network through binding to TIP47 is required for env incorporation into virions and infectivity. J Virol 77: 6931-6945. doi:10.1128/JVI.77.12.6931-6945.2003. PubMed: 12768012.
5. Egan MA, Carruth LM, Rowell JF, Yu X, Siliciano RF, (1996) Human immunodeficiency virus type 1 envelope protein endocytosis mediated by a highly conserved intrinsic internalization signal in the cytoplasmic domain of gp41 is suppressed in the presence of the Pr55gag precursor protein. J Virol 70: 6547-6556. PubMed: 8794289.
6. Ohno H, Aguilar RC, Fournier MC, Hennecke S, Cosson P, et al. (1997) Interaction of endocytic signals from the HIV-1 envelope glycoprotein complex with members of the adaptor medium chain family. Virology 238: 305-315. doi:10.1006/viro.1997.8839. PubMed: 9400603.
7. Postler TS, Desrosiers,. (2013) RC The tale of the long tail: the cytoplasmic domain of HIV-1 gp41. J Virol 87: 2-15. doi:10.1128/JVI.02053-12. PubMed: 23077317.
8. Checkley MA, Luttge BG, Freed EO,. (2011) HIV-1 envelope glycoprotein biosynthesis, trafficking, and incorporation. J Mol Biol 410: 582-608. doi:10.1016/j.jmb.2011.04.042. PubMed: 21762802.
9. Retroviral Murakami T, env glycoprotein trafficking and incorporation into virions Mol Biol Int 2012: 682850.
10. Johnson MC Mechanisms for Env glycoprotein acquisition by retroviruses. AIDS Res Hum Retroviruses 27: 239-247.
11. Jouvenet N, Bieniasz PD, Simon SM, (2008) Imaging the biogenesis of individual HIV-1 virions in live cells. Nature 454: 236-240. doi:10.1038/nature06998. PubMed: 18500329.
12. Ivanchenko S, Godinez WJ, Lampe M, Kräusslich HG, Eils R, et al. (2009) Dynamics of HIV-1 assembly and release. PLOS Pathog 5: e1000652. PubMed: 19893629.
13. Neil SJ, Zang T, Bieniasz PD, (2008) Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 451: 425-430. doi:10.1038/nature06553. PubMed: 18200009.
14. Chiu YL, Soros VB, Kreisberg JF, Stopak K, Yonemoto W, et al. (2005) Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells. Nature 435: 108-114. doi:10.1038/nature03493. PubMed: 15829920.
15. Goff SP, (2007) Host factors exploited by retroviruses. Nat Rev Microbiol 5: 253-263. doi:10.1038/nrmicro1541. PubMed: 17325726.
16. Azevedo C, Burton A, Ruiz-Mateos E, Marsh M, Saiardi A, (2009) Inositol pyrophosphate mediated pyrophosphorylation of AP3B1 regulates HIV-1 Gag release. Proc Natl Acad Sci U S A 106: 21161-21166. doi:10.1073/pnas.0909176106. PubMed: 19934039.
17. Brass AL, Dykxhoorn DM, Benita Y, Yan N, Engelman A, et al. (2008) Identification of host proteins required for HIV infection through a functional genomic screen. Science 319: 921-926. doi:10.1126/science.1152725. PubMed: 18187620.
18. Martinez NW, Xue X, Berro RG, Kreitzer G, Resh MD, (2008) Kinesin KIF4 regulates intracellular trafficking and stability of the human immunodeficiency virus type 1 Gag polyprotein. J Virol 82: 9937-9950. doi:10.1128/JVI.00819-08. PubMed: 18684836.
19. Alroy I, Tuvia S, Greener T, Gordon D, Barr HM, et al. (2005) The trans-Golgi network-associated human ubiquitin-protein ligase POSH is essential for HIV type 1 production. Proc Natl Acad Sci U S A 102: 1478-1483. doi:10.1073/pnas.0408717102. PubMed: 15659549.
20. Ryo A, Tsurutani N, Ohba K, Kimura R, Komano J, et al. (2008) SOCS1 is an inducible host factor during HIV-1 infection and regulates the intracellular trafficking and stability of HIV-1 Gag. Proc Natl Acad Sci U S A 105: 294-299. doi:10.1073/pnas.0704831105. PubMed: 18172216.
21. Murray JL, Mavrakis M, McDonald NJ, Yilla M, Sheng J, et al. (2005) Rab9 GTPase is required for replication of human immunodeficiency virus type 1, filoviruses, and measles virus. J Virol 79: 11742-11751. doi:10.1128/JVI.79.18.11742-11751.2005. PubMed: 16140752.
22. Camus G, Segura-Morales C, Molle D, Lopez-Vergès S, Begon-Pescia C, et al. (2007) The clathrin adaptor complex AP-1 binds HIV-1 and MLV Gag and facilitates their budding. Mol Biol Cell 18: 3193-3203. doi:10.1091/mbc.E06-12-1147. PubMed: 17538020.
23. Batonick M, Favre M, Boge M, Spearman P, Höning S, et al. (2005) Interaction of HIV-1 Gag with the clathrin-associated adaptor AP-2. Virology 342: 190-200. doi:10.1016/j.virol.2005.08.001. PubMed: 16139856.
24. Boge M, Wyss S, Bonifacino JS, Thali M, (1998) A membrane-proximal tyrosine-based signal mediates internalization of the HIV-1 envelope glycoprotein via interaction with the AP-2 clathrin adaptor. J Biol Chem 273: 15773-15778. doi:10.1074/jbc.273.25.15773. PubMed: 9624176.
25. Dong X, Li H, Derdowski A, Ding L, Burnett A, et al. (2005) AP-3 directs the intracellular trafficking of HIV-1 Gag and plays a key role in particle assembly. Cell 120: 663-674. doi:10.1016/j.cell.2004.12.023. PubMed: 15766529.
26. Bauby H, Lopez-Vergès S, Hoeffel G, Delcroix-Genête D, Janvier K, et al. (2010) TIP47 is required for the production of infectious HIV-1 particles from primary macrophages. Traffic 11: 455-467. doi:10.1111/j.1600-0854.2010.01036.x. PubMed: 20070608.
27. Lopez-Vergès S, Camus G, Blot G, Beauvoir R, Benarous R, et al. (2006) Tail-interacting protein TIP47 is a connector between Gag and Env and is required for Env incorporation into HIV-1 virions. Proc Natl Acad Sci U S A 103: 14947-14952. doi:10.1073/pnas.0602941103. PubMed: 17003132.
28. Chatel-Chaix L, Clément JF, Martel C, Bériault V, Gatignol A, et al. (2004) Identification of Staufen in the human immunodeficiency virus type 1 Gag ribonucleoprotein complex and a role in generating infectious viral particles. Mol Cell Biol 24: 2637-2648. doi:10.1128/MCB.24.7.2637-2648.2004. PubMed: 15024055.
29. Joshi A, Garg H, Nagashima K, Bonifacino JS, Freed EO, (2008) GGA and Arf proteins modulate retrovirus assembly and release. Mol Cell 30: 227-238. doi:10.1016/j.molcel.2008.03.015. PubMed: 18439901.
30. Joshi A, Garg H, Ablan SD, Freed, EO Evidence of a role for soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) machinery in HIV-1 assembly and release. J Biol Chem.
31. Lingappa JR, Dooher JE, Newman MA, Kiser PK, Klein KC, (2006) Basic residues in the nucleocapsid domain of Gag are required for interaction of HIV-1 gag with ABCE1 (HP68), a cellular protein important for HIV-1 capsid assembly. J Biol Chem 281: 3773-3784. doi:10.1074/jbc.M507255200. PubMed: 16275648.
32. Grigorov B, Attuil-Audenis V, Perugi F, Nedelec M, Watson S, et al. (2009) A role for CD81 on the late steps of HIV-1 replication in a chronically infected T cell line. Retrovirology 6: 28. doi:10.1186/1742-4690-6-S2-P28. PubMed: 19284574.
33. Ono A, Ablan SD, Lockett SJ, Nagashima K, Freed EO, (2004) Phosphatidylinositol (4,5) bisphosphate regulates HIV-1 Gag targeting to the plasma membrane. Proc Natl Acad Sci U S A 101: 14889-14894. doi:10.1073/pnas.0405596101. PubMed: 15465916.
34. Ono A, Freed EO, (2001) Plasma membrane rafts play a critical role in HIV-1 assembly and release. Proc Natl Acad Sci U S A 98: 13925-13930. doi:10.1073/pnas.241320298. PubMed: 11717449.
35. Popov S, Strack B, Sanchez-Merino V, Popova E, Rosin H, et al. (2011) Human immunodeficiency virus type 1 and related primate lentiviruses engage clathrin through Gag-Pol or Gag. J Virol 85: 3792-3801. doi:10.1128/JVI.02329-10. PubMed: 21289110.
36. Garrus JE, von Schwedler UK, Pornillos OW, Morham SG, Zavitz KH, et al. (2001) Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell 107: 55-65. doi:10.1016/S0092-8674(01)00506-2. PubMed: 11595185.
37. Strack B, Calistri A, Craig S, Popova E, Göttlinger HG, (2003) AIP1/ALIX is a binding partner for HIV-1 p6 and EIAV p9 functioning in virus budding. Cell 114: 689-699. doi:10.1016/S0092-8674(03)00653-6. PubMed: 14505569.
38. Hermida-Matsumoto L, Resh MD, (2000) Localization of human immunodeficiency virus type 1 Gag and Env at the plasma membrane by confocal imaging. J Virol 74: 8670-8679. doi:10.1128/JVI.74.18.8670-8679.2000. PubMed: 10954568.
39. Lodge R, Göttlinger H, Gabuzda D, Cohen EA, Lemay G, (1994) The intracytoplasmic domain of gp41 mediates polarized budding of human immunodeficiency virus type 1 in MDCK cells. J Virol 68: 4857-4861. PubMed: 8035484.
40. Lodge R, Lalonde JP, Lemay G, Cohen EA, (1997) The membrane-proximal intracytoplasmic tyrosine residue of HIV-1 envelope glycoprotein is critical for basolateral targeting of viral budding in MDCK cells. EMBO J 16: 695-705. doi:10.1093/emboj/16.4.695. PubMed: 9049299.
41. Deschambeault J, Lalonde JP, Cervantes-Acosta G, Lodge R, Cohen EA, et al. (1999) Polarized human immunodeficiency virus budding in lymphocytes involves a tyrosine-based signal and favors cell-to-cell viral transmission. J Virol 73: 5010-5017. PubMed: 10233963.
42. Owens RJ, Dubay JW, Hunter E, Compans RW, (1991) Human immunodeficiency virus envelope protein determines the site of virus release in polarized epithelial cells. Proc Natl Acad Sci U S A 88: 3987-3991. doi:10.1073/pnas.88.9.3987. PubMed: 2023946.
43. Sandrin V, Muriaux D, Darlix JL, Cosset FL, (2004) Intracellular trafficking of Gag and Env proteins and their interactions modulate pseudotyping of retroviruses. J Virol 78: 7153-7164. doi:10.1128/JVI.78.13.7153-7164.2004. PubMed: 15194792.
44. Davis MR, Jiang J, Zhou J, Freed EO, Aiken C, (2006) A mutation in the human immunodeficiency virus type 1 Gag protein destabilizes the interaction of the envelope protein subunits gp120 and gp41. J Virol 80: 2405-2417. doi:10.1128/JVI.80.5.2405-2417.2006. PubMed: 16474147.
45. Lambelé M, Labrosse B, Roch E, Moreau A, Verrier B, et al. (2007) Impact of natural polymorphism within the gp41 cytoplasmic tail of human immunodeficiency virus type 1 on the intracellular distribution of envelope glycoproteins and viral assembly. J Virol 81: 125-140. doi:10.1128/JVI.01659-06. PubMed: 17050592.
46. Jorgenson RL, Vogt VM, Johnson MC, (2009) Foreign glycoproteins can be actively recruited to virus assembly sites during pseudotyping. J Virol 83: 4060-4067. doi:10.1128/JVI.02425-08. PubMed: 19224995.
47. Weclewicz K, Ekström M, Kristensson K, Garoff H, (1998) Specific interactions between retrovirus Env and Gag proteins in rat neurons. J Virol 72: 2832-2845. PubMed: 9525603.
48. Lee YM, Tang XB, Cimakasky LM, Hildreth JE, Yu XF, (1997) Mutations in the matrix protein of human immunodeficiency virus type 1 inhibit surface expression and virion incorporation of viral envelope glycoproteins in CD4+ T lymphocytes. J Virol 71: 1443-1452. PubMed: 8995670.
49. Jaber T, Bohl CR, Lewis GL, Wood C, West JT Jr., et al. (2009) Human Ubc9 contributes to production of fully infectious human immunodeficiency virus type 1 virions. J Virol 83: 10448-10459. doi:10.1128/JVI.00237-09. PubMed: 19640976.
50. Zhao J, (2007) Sumoylation regulates diverse biological processes. Cell Mol Life Sci 64: 3017-3033. doi:10.1007/s00018-007-7137-4. PubMed: 17763827.
51. Geiss-Friedlander R, Melchior F, (2007) Concepts in sumoylation: a decade on. Nat Rev Mol Cell Biol 8: 947-956. doi:10.1038/nrm2293. PubMed: 18000527.
52. Guo Y, Yang MC, Weissler JC, Yang YS, (2008) Modulation of PLAGL2 transactivation activity by Ubc9 co-activation not SUMOylation. Biochem Biophys Res Commun 374: 570-575. doi:10.1016/j.bbrc.2008.07.064. PubMed: 18655774.
53. Chang YL, Huang CJ, Chan JY, Liu PY, Chang HP, et al. (2007) Regulation of nuclear receptor and coactivator functions by the carboxyl terminus of ubiquitin-conjugating enzyme 9. Int J Biochem Cell Biol 39: 1035-1046. doi:10.1016/j.biocel.2007.02.002. PubMed: 17336575.
54. Pan X, Li H, Zhang P, Jin B, Man J, et al. (2006) Ubc9 interacts with SOX4 and represses its transcriptional activity. Biochem Biophys Res Commun 344: 727-734. doi:10.1016/j.bbrc.2006.03.194. PubMed: 16631117.
55. Tomoiu A, Gravel A, Tanguay RM, Flamand L, (2006) Functional interaction between human herpesvirus 6 immediate-early 2 protein and ubiquitin-conjugating enzyme 9 in the absence of sumoylation. J Virol 80: 10218-10228. doi:10.1128/JVI.00375-06. PubMed: 17005699.
56. Saltzman A, Searfoss G, Marcireau C, Stone M, Ressner R, et al. (1998) hUBC9 associates with MEKK1 and type I TNF-alpha receptor and stimulates NFkappaB activity. FEBS Lett 425: 431-435. doi:10.1016/S0014-5793(98)00287-7. PubMed: 9563508.
57. Liu LB, Omata W, Kojima I, Shibata H, (2007) The SUMO conjugating enzyme Ubc9 is a regulator of GLUT4 turnover and targeting to the insulin-responsive storage compartment in 3T3-L1 adipocytes. Diabetes 56: 1977-1985. doi:10.2337/db06-1100. PubMed: 17536066.
58. Kurtzman AL, Schechter N, (2001) Ubc9 interacts with a nuclear localization signal and mediates nuclear localization of the paired-like homeobox protein Vsx-1 independent of SUMO-1 modification. Proc Natl Acad Sci U S A 98: 5602-5607. doi:10.1073/pnas.101129698. PubMed: 11331779.
59. Argasinska J, Zhou K, Donnelly RJ, Hay RT, Lee CG, (2004) A functional interaction between RHA and Ubc9, an E2-like enzyme specific for Sumo-1. J Mol Biol 341: 15-25. doi:10.1016/j.jmb.2004.06.004. PubMed: 15312759.
60. Boggio R, Chiocca S, (2006) Viruses and sumoylation: recent highlights. Curr Opin Microbiol 9: 430-436. doi:10.1016/j.mib.2006.06.008. PubMed: 16815735.
61. Wilson VG, Deyrieux AF, Wilson VG, (2009) Viral Interplay with the Host Sumoylation System. Sumo Regulation Cell Processes Springer Neth Pp. 315.
62. Boggio R, Chiocca S, (2005) Gam1 and the SUMO pathway. Cell Cycle 4: 533-535. doi:10.4161/cc.4.4.1605. PubMed: 15876861.
63. Adachi A, Gendelman HE, Koenig S, Folks T, Willey R, et al. (1986) Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol 59: 284-291. PubMed: 3016298.
64. Bosch V, Pawlita M, (1990) Mutational analysis of the human immunodeficiency virus type 1 env gene product proteolytic cleavage site. J Virol 64: 2337-2344. PubMed: 2182911.
65. Salzwedel K, West JT, Hunter E, (1999) A conserved tryptophan-rich motif in the membrane-proximal region of the human immunodeficiency virus type 1 gp41 ectodomain is important for Env-mediated fusion and virus infectivity. J Virol 73: 2469-2480. PubMed: 9971832.
66. Salzwedel K, Johnston PB, Roberts SJ, Dubay JW, Hunter E, (1993) Expression and characterization of glycophospholipid-anchored human immunodeficiency virus type 1 envelope glycoproteins. J Virol 67: 5279-5288. PubMed: 8102410.
67. Jejcic A, Daniels R, Goobar-Larsson L, Hebert DN, Vahlne A, (2009) Small molecule targets Env for endoplasmic reticulum-associated protein degradation and inhibits human immunodeficiency virus type 1 propagation. J Virol 83: 10075-10084. doi:10.1128/JVI.01700-08. PubMed: 19640982.
68. Bhattacharya J, Peters PJ, Clapham PR, (2004) Human immunodeficiency virus type 1 envelope glycoproteins that lack cytoplasmic domain cysteines: impact on association with membrane lipid rafts and incorporation onto budding virus particles. J Virol 78: 5500-5506. doi:10.1128/JVI.78.10.5500-5506.2004. PubMed: 15113929.
69. Wessel D, Flügge UI, (1984) A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids. Anal Biochem 138: 141-143. doi:10.1016/0003-2697(84)90782-6. PubMed: 6731838.
70. Abrahamyan LG, Mkrtchyan SR, Binley J, Lu M, Melikyan GB, et al. (2005) The cytoplasmic tail slows the folding of human immunodeficiency virus type 1 Env from a late prebundle configuration into the six-helix bundle. J Virol 79: 106-115. doi:10.1128/JVI.79.1.106-115.2005. PubMed: 15596806.
71. Römisch K, (2005) Endoplasmic reticulum-associated degradation. Annu Rev Cell Dev Biol 21: 435-456. doi:10.1146/annurev.cellbio.21.012704.133250. PubMed: 16212502.
72. Meusser B, Hirsch C, Jarosch E, Sommer T, (2005) ERAD: the long road to destruction. Nat Cell Biol 7: 766-772. doi:10.1038/ncb0805-766. PubMed: 16056268.
73. Vembar SS, Brodsky JL, (2008) One step at a time: endoplasmic reticulum-associated degradation. Nat Rev Mol Cell Biol 9: 944-957. doi:10.1038/nrm2546. PubMed: 19002207.
74. Courageot J, Fenouillet E, Bastiani P, Miquelis R, (1999) Intracellular degradation of the HIV-1 envelope glycoprotein. Evidence for, and some characteristics of, an endoplasmic reticulum degradation pathway. Eur J Biochem 260: 482-489. PubMed: 10095785.
75. Elder JH, Alexander S, (1982) endo-beta-N-acetylglucosaminidase F: endoglycosidase from Flavobacterium meningosepticum that cleaves both high-mannose and complex glycoproteins. Proc Natl Acad Sci U S A 79: 4540-4544. doi:10.1073/pnas.79.15.4540. PubMed: 6812050.
76. Schröder M, Kaufman RJ, (2005) ER stress and the unfolded protein response. Mutat Res 569: 29-63. doi:10.1016/j.mrfmmm.2004.06.056. PubMed: 15603751.
77. Maley F, Trimble RB, Tarentino AL, Plummer TH Jr., (1989) Characterization of glycoproteins and their associated oligosaccharides through the use of endoglycosidases. Anal Biochem 180: 195-204. doi:10.1016/0003-2697(89)90115-2. PubMed: 2510544.
78. Stein BS, Engleman EG, (1990) Intracellular processing of the gp160 HIV-1 envelope precursor. Endoproteolytic cleavage occurs in a cis or medial compartment of the Golgi complex. J Biol Chem 265: 2640-2649. PubMed: 2406237.
79. Bernstein HB, Tucker SP, Hunter E, Schutzbach JS, Compans RW, (1994) Human immunodeficiency virus type 1 envelope glycoprotein is modified by O-linked oligosaccharides. J Virol 68: 463-468. PubMed: 8254757.
80. Salzwedel K, West JT Jr., Mulligan MJ, Hunter E, (1998) Retention of the human immunodeficiency virus type 1 envelope glycoprotein in the endoplasmic reticulum does not redirect virus assembly from the plasma membrane. J Virol 72: 7523-7531. PubMed: 9696849.
81. Coffin JM, Hughes SH, Varmus H, (1997) Retroviruses. xv. Plainview, NY: Cold Spring Harbor Laboratory Press. 843pp.
82. Freed EO, Myers DJ, Risser R, (1989) Mutational analysis of the cleavage sequence of the human immunodeficiency virus type 1 envelope glycoprotein precursor gp160. J Virol 63: 4670-4675. PubMed: 2677400.
83. Hallenberger S, Bosch V, Angliker H, Shaw E, Klenk HD, et al. (1992) Inhibition of furin-mediated cleavage activation of HIV-1 glycoprotein gp160. Nature 360: 358-361. doi:10.1038/360358a0. PubMed: 1360148.
84. Leonard CK, Spellman MW, Riddle L, Harris RJ, Thomas JN, et al. (1990) Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells. J Biol Chem 265: 10373-10382. PubMed: 2355006.
85. Willey RL, Klimkait T, Frucht DM, Bonifacino JS, Martin MA, (1991) Mutations within the human immunodeficiency virus type 1 gp160 envelope glycoprotein alter its intracellular transport and processing. Virology 184: 319-329. doi:10.1016/0042-6822(91)90848-6. PubMed: 1871974.
86. Earl PL, Moss B, Doms RW, (1991) Folding, interaction with GRP78-BiP, assembly, and transport of the human immunodeficiency virus type 1 envelope protein. J Virol 65: 2047-2055. PubMed: 1900540.
87. Dubay JW, Dubay SR, Shin HJ, Hunter E, (1995) Analysis of the cleavage site of the human immunodeficiency virus type 1 glycoprotein: requirement of precursor cleavage for glycoprotein incorporation. J Virol 69: 4675-4682. PubMed: 7609032.
88. van Roy F, Berx G, (2008) The cell-cell adhesion molecule E-cadherin. Cell Mol Life Sci 65: 3756-3788. doi:10.1007/s00018-008-8281-1. PubMed: 18726070.
89. Bryant DM, Stow JL, (2004) The ins and outs of E-cadherin trafficking. Trends Cell Biol 14: 427-434. doi:10.1016/j.tcb.2004.07.007. PubMed: 15308209.
90. Christoffersen NR, Silahtaroglu A, Orom UA, Kauppinen S, Lund AH, (2007) miR-200b mediates post-transcriptional repression of ZFHX1B. RNA 13: 1172-1178. doi:10.1261/rna.586807. PubMed: 17585049.
91. Korpal M, Lee ES, Hu G, Kang Y, (2008) The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem 283: 14910-14914. doi:10.1074/jbc.C800074200. PubMed: 18411277.
92. Park SM, Gaur AB, Lengyel E, Peter ME, (2008) The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev 22: 894-907. doi:10.1101/gad.1640608. PubMed: 18381893.
93. Zhu S, Sachdeva M, Wu F, Lu Z, Mo,. (2010) YY Ubc9 promotes breast cell invasion and metastasis in a sumoylation-independent manner. Oncogene 29: 1763-1772. doi:10.1038/onc.2009.459. PubMed: 20023705.
94. Berlioz-Torrent C, Shacklett BL, Erdtmann L, Delamarre L, Bouchaert I, et al. (1999) Interactions of the cytoplasmic domains of human and simian retroviral transmembrane proteins with components of the clathrin adaptor complexes modulate intracellular and cell surface expression of envelope glycoproteins. J Virol 73: 1350-1361. PubMed: 9882340.
95. Waheed AA, Freed,. (2010) EO The Role of Lipids in Retrovirus Replication. Viruses 2: 1146-1180. doi:10.3390/v2051146. PubMed: 20740061.
96. Ono A Relationships between plasma membrane microdomains and HIV-1 assembly. Biol Cell 102: 335-350.
97. Bhattacharya J, Repik A, Clapham PR, (2006) Gag regulates association of human immunodeficiency virus type 1 envelope with detergent-resistant membranes. J Virol 80: 5292-5300. doi:10.1128/JVI.01469-05. PubMed: 16699009.
98. Patil A, Gautam A, Bhattacharya,. (2010) J Evidence that Gag facilitates HIV-1 envelope association both in GPI-enriched plasma membrane and detergent resistant membranes and facilitates envelope incorporation onto virions in primary CD4+ T cells. Virol J 7: 3. doi:10.1186/1743-422X-7-3. PubMed: 20064199.
99. Schubert U, Ott DE, Chertova EN, Welker R, Tessmer U, et al. (2000) Proteasome inhibition interferes with gag polyprotein processing, release, and maturation of HIV-1 and HIV-2. Proc Natl Acad Sci U S A 97: 13057-13062. doi:10.1073/pnas.97.24.13057. PubMed: 11087859.
100. Bültmann A, Eberle J, Haas J, (2000) Ubiquitination of the human immunodeficiency virus type 1 env glycoprotein. J Virol 74: 5373-5376. doi:10.1128/JVI.74.11.5373-5376.2000. PubMed: 10799617.
101. McGowan EB, Becker E, Detwiler TC, (1989) Inhibition of calpain in intact platelets by the thiol protease inhibitor E-64d. Biochem Biophys Res Commun 158: 432-435. doi:10.1016/S0006-291X(89)80065-8. PubMed: 2537073.
102. Rich DH, Bernatowicz MS, Agarwal NS, Kawai M, Salituro FG, et al. (1985) Inhibition of aspartic proteases by pepstatin and 3-methylstatine derivatives of pepstatin. Evidence for collected-substrate enzyme inhibition. Biochemistry 24: 3165-3173. doi:10.1021/bi00334a014. PubMed: 3927973.
103. Aoyagi T, Takeuchi T, Matsuzaki A, Kawamura K, Kondo S, (1969) Leupeptins, new protease inhibitors from Actinomycetes. J Antibiot (Tokyo) 22: 283-286. doi:10.7164/antibiotics.22.283. PubMed: 5810993.
104. Rizos H, Woodruff S, Kefford, (2005) RF: pp. 14ARF interacts with the SUMO-conjugating enzyme Ubc9 and promotes the sumoylation of its binding partners. Cell Cycle 4: 597-603.
105. Mishra RK, Jatiani SS, Kumar A, Simhadri VR, Hosur RV, et al. (2004) Dynamin interacts with members of the sumoylation machinery. J Biol Chem 279: 31445-31454. doi:10.1074/jbc.M402911200. PubMed: 15123615.
106. Zamborlini A, Coiffic A, Beauclair G, Delelis O, Paris J, et al. (2011) Impairment of Human Immunodeficiency Virus Type-1 Integrase SUMOylation Correlates with an Early Replication Defect. J Biol Chem 286: 21013-21022. doi:10.1074/jbc.M110.189274. PubMed: 21454548.
107. Chertova E, Chertov O, Coren LV, Roser JD, Trubey CM, et al. (2006) Proteomic and biochemical analysis of purified human immunodeficiency virus type 1 produced from infected monocyte-derived macrophages. J Virol 80: 9039-9052. doi:10.1128/JVI.01013-06. PubMed: 16940516.
108. Gurer C, Berthoux L, Luban J, (2005) Covalent modification of human immunodeficiency virus type 1 p6 by SUMO-1. J Virol 79: 910-917. doi:10.1128/JVI.79.2.910-917.2005. PubMed: 15613319.
109. Wyatt D, Malik R, Vesecky AC, Small Marchese A,. (2011) ubiquitin-like modifier modification of arrestin-3 regulates receptor trafficking. J Biol Chem 286: 3884-3893. doi:10.1074/jbc.M110.152116. PubMed: 21118812.
110. Murakami T, Freed EO, (2000) Genetic evidence for an interaction between human immunodeficiency virus type 1 matrix and alpha-helix 2 of the gp41 cytoplasmic tail. J Virol 74: 3548-3554. doi:10.1128/JVI.74.8.3548-3554.2000. PubMed: 10729129.
111. Murakami T, Freed EO, (2000) The long cytoplasmic tail of gp41 is required in a cell type-dependent manner for HIV-1 envelope glycoprotein incorporation into virions. Proc Natl Acad Sci U S A 97: 343-348. doi:10.1073/pnas.97.1.343. PubMed: 10618420.
112. Freed EO, Martin MA, (1996) Domains of the human immunodeficiency virus type 1 matrix and gp41 cytoplasmic tail required for envelope incorporation into virions. J Virol 70: 341-351. PubMed: 8523546.
113. Freed EO, Martin MA, (1995) Virion incorporation of envelope glycoproteins with long but not short cytoplasmic tails is blocked by specific, single amino acid substitutions in the human immunodeficiency virus type 1 matrix. J Virol 69: 1984-1989. PubMed: 7853546.
114. Byland R, Vance PJ, Hoxie JA, Marsh M, (2007) A conserved dileucine motif mediates clathrin and AP-2-dependent endocytosis of the HIV-1 envelope protein. Mol Biol Cell 18: 414-425. PubMed: 17108326.
115. Motley A, Bright NA, Seaman MN, Robinson MS, (2003) Clathrin-mediated endocytosis in AP-2-depleted cells. J Cell Biol 162: 909-918. doi:10.1083/jcb.200305145. PubMed: 12952941.
116. Sato K, Watanabe T, Wang S, Kakeno M, Matsuzawa K, et al. (2011) Numb controls E-cadherin endocytosis through p120 catenin with aPKC. Mol Biol Cell 22: 3103-3119. doi:10.1091/mbc.E11-03-0274. PubMed: 21775625.
117. Jiang J, Aiken C, (2007) Maturation-dependent human immunodeficiency virus type 1 particle fusion requires a carboxyl-terminal region of the gp41 cytoplasmic tail. J Virol 81: 9999-10008. doi:10.1128/JVI.00592-07. PubMed: 17609279.